The Indiana Department of Health is accepting applications for its Alzheimer’s Disease Pre-Clinical Translational Science Grant.
Donor Name: Indiana Department of Health (IDOH)
State: Indiana
County: All Counties
Type of Grant: Grant
Deadline: 07/07/2026
Size of the Grant: $10,000 to $100,000
Grant Duration: Grant Duration Not Mentioned
Details:
This funding opportunity supports innovative research aligned with the activities of the IUSM–Purdue TREAT-AD Center and is open to Indiana CTSI investigators holding full-time academic appointments.
These include (but are not limited to):
- Bioinformatic analyses and drug target hypothesis generation within neuroinflammatory pathways
- Target validation studies for proposed drug targets
- Innovative chemical biology and cellular pharmacology studies for proposed targets that provide insights to disease initiation and progression
- Structural biology or biophysical studies on proteins proposed as drug targets
- De-novo drug design approaches for proposed targets
- Novel PET ligands and supporting CSF biomarkers for preclinical studies and clinical trials, etc.
Funding Information
Costs may not exceed $50,000.
Eligibility Criteria
Applicants belong to the following three categories are eligible to apply:
- category 1: New investigators without current or past NIH research support as PD/PI. New investigators, as defined by the NIH, should not have previously competed successfully for a substantial (e.g., R01) NIH-supported independent research award.
- category 2: Established investigators who do not belong to Category 1 and do not have Alzheimer’s disease drug discovery experience but wish to apply to enhance their current research.
- category 3: Established Alzheimer’s disease drug discovery investigators who do not belong to Category 1 & 2 and propose testing innovative ideas that represent clear departure from ongoing research interests.
For more information, visit IDOH.
